Status:

RECRUITING

Dronabinol After Arthroscopic Surgery

Lead Sponsor:

Northwestern University

Conditions:

Knee Osteoarthritis

Knee Injuries

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pa...

Eligibility Criteria

Inclusion

  • Age 18 years or older
  • Patient who will undergo arthroscopic surgery of the knee including, but not limited to,
  • Meniscectomy
  • Synovectomy
  • Chondroplasty
  • Loose body removal

Exclusion

  • Patients under age 18 years
  • Patients who cannot provide consent
  • Patients who are pregnant, breast feeding, or are trying to become pregnant during the study period
  • Patients with an allergy to any of the study drugs
  • Patient who are lactose-intolerant
  • Revision surgery
  • Open surgery
  • Comorbidities preventing surgery
  • Patients with a history of mania, depression, or schizophrenia
  • Patients taking any of the following drugs or supplements
  • Anticholinergic agents
  • Benzodiazepines
  • Central nervous system depressants
  • Droperidol
  • Hydroxyzine
  • Levomepromazine or methotrimeprazine
  • Monoamine oxidase inhibitors
  • Ritonavir
  • Selective serotonin reuptake inhibitors
  • Sympathomimetics
  • St. John's Wort
  • Current diagnosed alcohol or drug abuse
  • Patients who cannot or will not abide by the medication restrictions listed below
  • Medication restrictions
  • Participants must agree to abstain from using recreational or medical marijuana products or cannabidiol (CBD) in any form during the treatment period
  • Participants should not drink alcohol or take other drugs while taking the study drug or hydrocodone/acetaminophen

Key Trial Info

Start Date :

June 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05335252

Start Date

June 28 2022

End Date

June 1 2027

Last Update

April 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States, 60611